Forbes June 24, 2020
This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis.
But the legislation would do nothing to address the root causes of Obamacare’s unaffordability. Worse still, it would fund these new subsidies by taking money from drug companies through a combination of price controls and taxes.
The world desperately needs effective vaccines and treatments for Covid-19. And Democrats want to raid the coffers of the companies investing in that research, in order to line the pockets of insurance companies? That makes no...
Today's Sponsors
Today's Sponsor